FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert John Rodgers

Research Profile

Living Beings

Disorders

Anxiety

Activities & Behaviors

Chemicals & Drugs

Physiology

Concepts & Ideas

Procedures

Analgesia

Co-author Network

Publications

TOP 3
Tatiani Sorregotti; Joyce Mendes-Gomes; Javier Leonardo Rico; Robert John Rodgers; Ricardo Luiz Nunes-de-Souza
Ethopharmacological analysis of the open elevated plus-maze in mice.
Robert John Rodgers; N F Snow; F L Wright; L J Taylor
Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
F L Wright; Robert John Rodgers
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert John Rodgers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tatiani Sorregotti; Joyce Mendes-Gomes; Javier Leonardo Rico; Robert John Rodgers; Ricardo Luiz Nunes-de-Souza
Ethopharmacological analysis of the open elevated plus-maze in mice.
Behavioural brain research 2013;246():76-85.
2013: Robert John Rodgers; N F Snow; F L Wright; L J Taylor
Orexin-1 receptor antagonism fails to reduce anxiety-like behaviour in either plus-maze-naïve or plus-maze-experienced mice.
Behavioural brain research 2013;243():213-9.
2013: F L Wright; Robert John Rodgers
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats.
Psychopharmacology 2013;226(2):415-31.
2011: Vanessa Nunes-de-Souza; Robert John Rodgers; Ricardo Nunes-de-Souza; Azair Canto-de-Souza
Blockade of 5-HT(2) receptors in the periaqueductal grey matter (PAG) abolishes the anxiolytic-like effect of 5-HT(1A) receptor antagonism in the median raphe nucleus in mice.
Behavioural brain research 2011;225(2):547-53.
2011: Robert John Rodgers; Hannah Harvest; Claire Hassall; Laura Anne Kaddour
D-cycloserine enhances memory consolidation in the plus-maze retest paradigm.
Behavioral neuroscience 2011;125(1):106-16.
2010: Robert John Rodgers; P Holch; Amy J Tallett
Behavioural satiety sequence (BSS): separating wheat from chaff in the behavioural pharmacology of appetite.
Pharmacology, biochemistry, and behavior 2010;97(1):3-14.
2010: Amy J Tallett; John E Blundell; Robert John Rodgers
Effects of acute low-dose combined treatment with rimonabant and sibutramine on appetite and weight gain in rats.
Pharmacology, biochemistry, and behavior 2010;97(1):92-100.
2010: Amy J Tallett; John E Blundell; Robert John Rodgers
Sibutramine & naloxone: infra-additive interaction in the regulation of appetite?
Behavioural brain research 2010;207(1):174-81.
2009: Amy J Tallett; John E Blundell; Robert John Rodgers
Night and day: diurnal differences in the behavioural satiety sequence in male rats.
Physiology & behavior 2009;97(1):125-30.
2009: Amy J Tallett; John E Blundell; Robert John Rodgers
Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
Behavioural brain research 2009;198(2):359-65.
2008: L S Mathiasen; N R Mirza; Robert John Rodgers
Strain- and model-dependent effects of chlordiazepoxide, L-838,417 and zolpidem on anxiety-like behaviours in laboratory mice.
Pharmacology, biochemistry, and behavior 2008;90(1):19-36.
2008: Amy J Tallett; John E Blundell; Robert John Rodgers
Endogenous opioids and cannabinoids: system interactions in the regulation of appetite, grooming and scratching.
Physiology & behavior 2008;94(3):422-31.
2008: Amy J Tallett; John E Blundell; Robert John Rodgers
Behaviourally-selective hypophagic effects of naloxone in non-deprived male rats presented with palatable food.
Behavioural brain research 2008;187(2):417-27.
2008: Vanessa Nunes-de-Souza; Ricardo Luiz Nunes-de-Souza; Robert John Rodgers; Azair Canto-de-Souza
5-HT2 receptor activation in the midbrain periaqueductal grey (PAG) reduces anxiety-like behaviour in mice.
Behavioural brain research 2008;187(1):72-9.
2007: Amy J Tallett; John E Blundell; Robert John Rodgers
Grooming, scratching and feeding: role of response competition in acute anorectic response to rimonabant in male rats.
Psychopharmacology 2007;195(1):27-39.
2006: Robert John Rodgers; R Augar; N Berryman; C J Hansom; M L O'Mahony; R M Palmer; A Stevens; Amy J Tallett
Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes.
Psychopharmacology 2006;187(3):345-55.
2005: Robert John Rodgers; P M Evans; A Murphy
Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naïve and plus-maze-experienced mice.
Behavioural pharmacology 2005;16(5-6):405-13.
2005: Y Ishii; John E Blundell; Jason C G Halford; Neil Upton; R Porter; A Johns; Robert John Rodgers
Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S.
Behavioural brain research 2005;160(1):11-24.
2005: Y Ishii; John E Blundell; Jason C G Halford; Neil Upton; R Porter; A Johns; Phillip Jeffrey; Scott G Summerfield; Robert John Rodgers
Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.
Behavioural brain research 2005;157(2):331-41.
2004: Robert John Rodgers; C Gentsch; D Hoyer; E Bryant; A J Green; K Z Kolokotroni; J L Martin
The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze.
Behavioural brain research 2004;154(1):183-92.
2004: Y Ishii; John E Blundell; Jason C G Halford; Neil Upton; R Porter; A Johns; Robert John Rodgers
Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.
Physiology & behavior 2004;81(1):129-40.
2003: Y Ishii; John E Blundell; Jason C G Halford; Robert John Rodgers
Palatability, food intake and the behavioural satiety sequence in male rats.
Physiology & behavior 2003;80(1):37-47.
2003: Y Ishii; John E Blundell; Jason C G Halford; Robert John Rodgers
Effects of systematic variation in presatiation and fasting on the behavioural satiety sequence in male rats.
Physiology & behavior 2003;79(2):227-38.
2003: Robert John Rodgers; József Haller; J Halasz; Eva Mikics
'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.
The European journal of neuroscience 2003;17(6):1279-86.
2003: Andrew Holmes; Robert John Rodgers
Prior exposure to the elevated plus-maze sensitizes mice to the acute behavioral effects of fluoxetine and phenelzine.
European journal of pharmacology 2003;459(2-3):221-30.
2002: Robert John Rodgers; B Davies; Roger Shore
Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline.
Genes, brain, and behavior 2002;1(4):242-51.
2002: Robert John Rodgers; E Boullier; P Chatzimichalaki; G D Cooper; A Shorten
Contrasting phenotypes of C57BL/6JOlaHsd, 129S2/SvHsd and 129/SvEv mice in two exploration-based tests of anxiety-related behaviour.
Physiology & behavior 2002;77(2-3):301-10.
2002: Robert John Rodgers; Y Ishii; Jason C G Halford; John E Blundell
Orexins and appetite regulation.
Neuropeptides 2002;36(5):303-25.
2002: Azair Canto-de-Souza; Ricardo Luiz Nunes-de-Souza; Robert John Rodgers
Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
Brain research 2002;928(1-2):50-9.
2002: Ricardo Luiz Nunes-de-Souza; Azair Canto-de-Souza; Robert John Rodgers
Effects of intra-hippocampal infusion of WAY-100635 on plus-maze behavior in mice. Influence of site of injection and prior test experience.
Brain research 2002;927(1):87-96.
2001: Robert John Rodgers
Anxious genes, emerging themes. Commentary on Belzung "The genetic basis of the pharmacological effects of anxiolytics" and Olivier et al. "The 5-HT(1A) receptor knockout mouse and anxiety".
Behavioural pharmacology 2001;12(6-7):471-6.
2001: A Holmes; J P Iles; S J Mayell; Robert John Rodgers
Prior test experience compromises the anxiolytic efficacy of chlordiazepoxide in the mouse light/dark exploration test.
Behavioural brain research 2001;122(2):159-67.
2001: Robert John Rodgers; Jason C G Halford; Ricardo Luiz Nunes-de-Souza; Azair Canto-de-Souza; DC Piper; Jonathan R S Arch; Neil Upton; Rod A Porter; A Johns; John E Blundell
SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
The European journal of neuroscience 2001;13(7):1444-52.
2001: A Dalvi; Robert John Rodgers
Anxiolytic effects of valproate and diazepam in mice are differentially sensitive to picrotoxin antagonism.
Pharmacology, biochemistry, and behavior 2001;68(1):23-32.
2000: Robert John Rodgers; Jason C G Halford; Ricardo Luiz Nunes-de-Souza; Azair Canto-de-Souza; DC Piper; Jonathan R S Arch; John E Blundell
Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats.
Regulatory peptides 2000;96(1-2):71-84.
1999: Robert John Rodgers; József Haller; A Holmes; J Halasz; T J Walton; P F Brain
Corticosterone response to the plus-maze: high correlation with risk assessment in rats and mice.
Physiology & behavior 1999;68(1-2):47-53.
1999: A Holmes; Robert John Rodgers
Influence of spatial and temporal manipulations on the anxiolytic efficacy of chlordiazepoxide in mice previously exposed to the elevated plus-maze.
Neuroscience and biobehavioral reviews 1999;23(7):971-80.
1999: A Dalvi; Robert John Rodgers
Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance.
Pharmacology, biochemistry, and behavior 1999;62(4):727-34.
1998: BJ Cao; Robert John Rodgers
Comparative effects of novel 5-HT1A receptor ligands, LY293284, LY315712 and LY297996, on plus-maze anxiety in mice.
Psychopharmacology 1998;139(3):185-94.
1998: A Holmes; Robert John Rodgers
Responses of Swiss-Webster mice to repeated plus-maze experience: further evidence for a qualitative shift in emotional state?
Pharmacology, biochemistry, and behavior 1998;60(2):473-88.
1998: BJ Cao; Robert John Rodgers
Tolerance to acute anxiolysis but no withdrawal anxiogenesis in mice treated chronically with 5-HT1A receptor antagonist, WAY 100635.
Neuroscience and biobehavioral reviews 1998;23(2):247-57.
1998: Robert John Rodgers; N J Johnson
Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice.
Pharmacology, biochemistry, and behavior 1998;59(1):221-32.
1997: Robert John Rodgers
Animal models of 'anxiety': where next?
Behavioural pharmacology 1997;8(6-7):477-96; discussion 497-504.
1997: Robert John Rodgers; A Dalvi
Anxiety, defence and the elevated plus-maze.
Neuroscience and biobehavioral reviews 1997;21(6):801-10.
1997: BJ Cao; Robert John Rodgers
Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. II. WAY 100635, SDZ 216-525 and NAN-190.
Pharmacology, biochemistry, and behavior 1997;58(2):593-603.
1997: BJ Cao; Robert John Rodgers
Influence of 5-HT1A receptor antagonism on plus-maze behaviour in mice. I. Pindolol enantiomers and pindobind 5-HT1A.
Pharmacology, biochemistry, and behavior 1997;58(2):583-91.
1997: BJ Cao; Robert John Rodgers
Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.
European journal of pharmacology 1997;335(2-3):117-25.
1997: BJ Cao; Robert John Rodgers
Comparative behavioural profiles of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) in the murine elevated plus-maze.
Neuropharmacology 1997;36(8):1089-97.
1997: Guy Griebel; Robert John Rodgers; Ghislaine Perrault; D J Sanger
Risk assessment behaviour: evaluation of utility in the study of 5-HT-related drugs in the rat elevated plus-maze test.
Pharmacology, biochemistry, and behavior 1997;57(4):817-27.
1997: Robert John Rodgers; N J Johnson; J Carr; T P Hodgson
Resistance of experientially-induced changes in murine plus-maze behaviour to altered retest conditions.
Behavioural brain research 1997;86(1):71-7.
1997: Robert John Rodgers; MG Cutler; John Edward Jackson
Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline and fluvoxamine. II. The elevated plus-maze.
Pharmacology, biochemistry, and behavior 1997;57(1-2):127-36.
1997: MG Cutler; Robert John Rodgers; John Edward Jackson
Behavioural effects in mice of subchronic chlordiazepoxide, maprotiline, and fluvoxamine. I. Social interactions.
Pharmacology, biochemistry, and behavior 1997;57(1-2):119-25.
1997: Robert John Rodgers; BJ Cao; A Dalvi; A Holmes
Animal models of anxiety: an ethological perspective.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 1997;30(3):289-304.
1997: BJ Cao; Robert John Rodgers
Anxiolytic-like profile of p-MPPI, a novel 5HT1A receptor antagonist, in the murine elevated plus-maze.
Psychopharmacology 1997;129(4):365-71.
1997: Robert John Rodgers; MG Cutler; John Edward Jackson
Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. II. The elevated plus-maze.
Pharmacology, biochemistry, and behavior 1997;56(2):295-303.
1997: MG Cutler; Robert John Rodgers; John Edward Jackson
Behavioural effects in mice of subchronic buspirone, ondansetron and tianeptine. I. Social interactions.
Pharmacology, biochemistry, and behavior 1997;56(2):287-93.
1996: BJ Cao; Robert John Rodgers
Different behavioural profiles of the R(+)- and S(-)-enantiomers of 8-hydroxy-2-(di-n-propylamino) tetralin in the murine elevated plus-maze.
Behavioural pharmacology 1996;7(8):810-9.
1996: A Dalvi; Robert John Rodgers
GABAergic influences on plus-maze behaviour in mice.
Psychopharmacology 1996;128(4):380-97.
1996: Robert John Rodgers; N J Johnson; A J Champion; S Mills
Modulation of plus-maze behaviour in mice by the preferential D3-receptor agonist 7-OH-DPAT.
Pharmacology, biochemistry, and behavior 1996;54(1):79-84.
1996: Robert John Rodgers; N J Johnson; J C Cole; C V Dewar; G R Kidd; P H Kimpson
Plus-maze retest profile in mice: importance of initial stages of trail 1 and response to post-trail cholinergic receptor blockade.
Pharmacology, biochemistry, and behavior 1996;54(1):41-50.
1996: N J Johnson; Robert John Rodgers
Ethological analysis of cholecystokinin (CCKA and CCKB) receptor ligands in the elevated plus-maze test of anxiety in mice.
Psychopharmacology 1996;124(4):355-64.
1995: Robert John Rodgers; J C Cole; K Aboualfa; L H Stephenson
Ethopharmacological analysis of the effects of putative 'anxiogenic' agents in the mouse elevated plus-maze.
Pharmacology, biochemistry, and behavior 1995;52(4):805-13.
1995: J C Cole; Robert John Rodgers
Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.
Pharmacology, biochemistry, and behavior 1995;52(3):473-8.
1995: Robert John Rodgers; N J Johnson
Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety.
Pharmacology, biochemistry, and behavior 1995;52(2):297-303.
1995: J C Cole; G J Burroughs; C R Laverty; N C Sheriff; E A Sparham; Robert John Rodgers
Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.
Psychopharmacology 1995;118(4):425-36.
1995: Robert John Rodgers; J C Cole; J M Tredwell
Profile of action of 5-HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice.
Psychopharmacology 1995;117(3):306-12.
1995: Robert John Rodgers; N J Johnson; S J Norton; J C Cole
Effects of ritanserin and 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the murine elevated plus-maze test of anxiety: an ethopharmacological study.
Journal of psychopharmacology (Oxford, England) 1995;9(1):38-42.
1995: Robert John Rodgers; N J Johnson
Cholecystokinin and anxiety: promises and pitfalls.
Critical reviews in neurobiology 1995;9(4):345-69.
1994: Robert John Rodgers; E M Nikulina; J C Cole
Dopamine D1 and D2 receptor ligands modulate the behaviour of mice in the elevated plus-maze.
Pharmacology, biochemistry, and behavior 1994;49(4):985-95.
1994: Robert John Rodgers; J C Cole
Anxiolytic-like effect of (S)-WAY 100135, a 5-HT1A receptor antagonist, in the murine elevated plus-maze test.
European journal of pharmacology 1994;261(3):321-5.
1994: Robert John Rodgers; J C Cole; A Davies
Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan.
Pharmacology, biochemistry, and behavior 1994;48(4):959-63.
1994: J C Cole; Robert John Rodgers
Ethological evaluation of the effects of acute and chronic buspirone treatment in the murine elevated plus-maze test: comparison with haloperidol.
Psychopharmacology 1994;114(2):288-96.
1994: Robert John Rodgers; J C Cole; D J Harrison-Phillips
"Cohort removal" induces hyperthermia but fails to influence plus-maze behaviour in male mice.
Physiology & behavior 1994;55(1):189-92.
1993: Robert John Rodgers; J C Cole
Influence of social isolation, gender, strain, and prior novelty on plus-maze behaviour in mice.
Physiology & behavior 1993;54(4):729-36.
1993: Robert John Rodgers; J C Cole
Anxiety enhancement in the murine elevated plus maze by immediate prior exposure to social stressors.
Physiology & behavior 1993;53(2):383-8.
1993: Robert John Rodgers; J K Shepherd
Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/dark tests of anxiety in mice.
Psychopharmacology 1993;113(2):237-42.
1992: Robert John Rodgers; J K Shepherd
Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699.
Neuropharmacology 1992;31(6):553-60.
1992: Robert John Rodgers; C Lee; J K Shepherd
Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience.
Psychopharmacology 1992;106(1):102-10.
1991: C Lee; Robert John Rodgers
Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice.
Neuropharmacology 1991;30(12A):1263-7.
1991: Robert John Rodgers
A step in the right direction: comment on '5-HT and mechanisms of defence'.
Journal of psychopharmacology (Oxford, England) 1991;5(4):316-9.
1991: Robert John Rodgers; J K Shepherd; P Donát
Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice.
Neuroscience and biobehavioral reviews 1991;15(4):489-95.
1990: Robert John Rodgers; J K Shepherd
Stereospecific inhibition of non-opioid defeat analgesia in male mice by MDL 72832, a selective 5-HT1A receptor agonist.
European journal of pharmacology 1990;182(3):581-5.
1990: Robert John Rodgers; D C Blanchard; L K Wong; R J Blanchard
Effects of scopolamine on antipredator defense reactions in wild and laboratory rats.
Pharmacology, biochemistry, and behavior 1990;36(3):575-83.
1990: J K Shepherd; Robert John Rodgers
8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.
Psychopharmacology 1990;101(3):408-13.
1990: Robert John Rodgers; J K Shepherd; J I Randall
Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice.
Neuropharmacology 1990;29(1):17-23.
1990: C Lee; Robert John Rodgers
Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.
Psychopharmacology 1990;102(4):507-13.
1989: CA Hendrie; J K Shepherd; Robert John Rodgers
Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice.
Neuropharmacology 1989;28(10):1025-32.
1989: Robert John Rodgers; J K Shepherd
Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.
Psychopharmacology 1989;99(3):374-80.
1989: Robert John Rodgers; J K Shepherd
5HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), inhibits non-opioid analgesia in defeated mice: influence of route of administration.
Psychopharmacology 1989;97(2):163-5.
1988: J I Randall; Robert John Rodgers
Adaptive pain inhibition in murine resident-intruder interactions.
The International journal of neuroscience 1988;41(3-4):251-9.
1988: Robert John Rodgers; J I Randall
Potent inhibition of non-opioid defeat analgesia in male mice by benzodiazepine antagonist Ro15-3505.
Physiology & behavior 1988;42(5):461-4.
1988: Robert John Rodgers; J I Randall
Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands.
Psychopharmacology 1988;96(1):45-54.
1987: Robert John Rodgers; J I Randall
Social conflict analgesia: inhibition of early non-opioid component by diazepam or flumazepil fails to affect appearance of late opioid component.
Brain research bulletin 1987;19(1):141-4.
1987: Robert John Rodgers; J I Randall
Are the analgesic effects of social defeat mediated by benzodiazepine receptors?
Physiology & behavior 1987;41(3):279-89.